Search

everythinglearnresearchcommunity

for

Search:↓

A girl with severe hair loss saw hair regrowth after using cannabis.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Lichen planopilaris can occur with multiple autoimmune diseases.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Blood stasis is the main cause of spot baldness, and treatments should focus on improving blood circulation.

Adalimumab can cause complete hair loss in rare cases.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

HIV can cause unusual and severe skin problems that are hard to treat.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.